These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2847815)
1. [Photoactivated radioactive analogs of calcium antagonists of 1,4-dihydropyridine series: synthesis and covalent labeling of the receptor in rabbit skeletal muscle]. Soldatov NM Biokhimiia; 1988 Aug; 53(8):1247-55. PubMed ID: 2847815 [TBL] [Abstract][Full Text] [Related]
2. [Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups]. Soldatov NM Biokhimiia; 1988 Jul; 53(7):1059-68. PubMed ID: 2846077 [TBL] [Abstract][Full Text] [Related]
3. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines. Reynolds IJ; Snowman AM; Snyder SH J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067 [TBL] [Abstract][Full Text] [Related]
4. [Solubilization and isolation of dihydropyridine calcium channel blocker receptor from the rabbit skeletal muscle]. Soldatov NM Biokhimiia; 1988 Sep; 53(9):1418-26. PubMed ID: 2849480 [TBL] [Abstract][Full Text] [Related]
5. Radioligand binding studies on some dihydropyridine analogues as probes of the dihydropyridine receptor. Kettmann V; Drímal J; Svétlík J Pharmazie; 1996 Oct; 51(10):747-50. PubMed ID: 8941943 [TBL] [Abstract][Full Text] [Related]
6. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine. Glossmann H; Ferry DR; Goll A; Rombusch M J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403 [TBL] [Abstract][Full Text] [Related]
7. [Isolation and characteristics of dihydropyridine calcium antagonist receptor from rabbit skeletal muscles]. Soldatov NM Biokhimiia; 1988 Oct; 53(10):1600-11. PubMed ID: 2852965 [TBL] [Abstract][Full Text] [Related]
8. A novel high affinity class of Ca2+ channel blockers. Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787 [TBL] [Abstract][Full Text] [Related]
9. Primary structure of the receptor for calcium channel blockers from skeletal muscle. Tanabe T; Takeshima H; Mikami A; Flockerzi V; Takahashi H; Kangawa K; Kojima M; Matsuo H; Hirose T; Numa S Nature; 1987 Jul 23-29; 328(6128):313-8. PubMed ID: 3037387 [TBL] [Abstract][Full Text] [Related]
11. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker. Suh-Kim H; Wei X; Birnbaumer L Mol Pharmacol; 1996 Nov; 50(5):1330-7. PubMed ID: 8913365 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent. Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67. Lakitsch M; Knaus HG; Topar G; Romanin C; Boer R; Flockerzi D; Striessnig J; Schindler H; Hoeltje HD; Glossmann H Mol Pharmacol; 1993 Feb; 43(2):293-301. PubMed ID: 8381514 [TBL] [Abstract][Full Text] [Related]
14. Purification and affinity labeling of dihydropyridine receptor from rabbit skeletal muscle membranes. Kanngiesser U; Nalik P; Pongs O Proc Natl Acad Sci U S A; 1988 May; 85(9):2969-73. PubMed ID: 2834724 [TBL] [Abstract][Full Text] [Related]
15. Is Ca2+ antagonists binding protein from cytosolic fraction the precursor of alpha 1-subunit of Ca2+ channel? Krizanová O; Hudecová S; Orlický J; Zachar J Gen Physiol Biophys; 1989 Apr; 8(2):99-111. PubMed ID: 2550315 [TBL] [Abstract][Full Text] [Related]
16. Reconstitution of the purified receptor for calcium channel blockers. Sieber M; Nastainczyk W; Röhrkasten A; Hofmann F Biomed Biochim Acta; 1987; 46(8-9):S357-62. PubMed ID: 2829861 [TBL] [Abstract][Full Text] [Related]
17. Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies. Striessnig J; Scheffauer F; Mitterdorfer J; Schirmer M; Glossmann H J Biol Chem; 1990 Jan; 265(1):363-70. PubMed ID: 2152924 [TBL] [Abstract][Full Text] [Related]
18. Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers. Rovnyak G; Andersen N; Gougoutas J; Hedberg A; Kimball SD; Malley M; Moreland S; Porubcan M; Pudzianowski A J Med Chem; 1988 May; 31(5):936-44. PubMed ID: 2834556 [TBL] [Abstract][Full Text] [Related]
19. An antibody to dihydropyridine calcium entry blockers. A comparison with the calcium channel receptor in skeletal muscle. Thayer SA; Pham DH; Schultz CM; Minaskanian G; Fairhurst AS Biochem Pharmacol; 1986 Dec; 35(24):4479-85. PubMed ID: 3024651 [TBL] [Abstract][Full Text] [Related]
20. Dimeric 1,4-dihydropyridines as calcium channel antagonists. Joslyn AF; Luchowski E; Triggle DJ J Med Chem; 1988 Aug; 31(8):1489-92. PubMed ID: 2840498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]